ç¡æãã£ã³ã»ã«åæžïŒäºçŽåºåžçãæå€§åããæŠç¥

Turn this article into takeaways for your work.
Each assistant summarizes the article only for you and suggests best practices for your work.
空ããäºçŽæ ã¯ãäºåºŠãšæ»ããªããéãæå³ããŸããå»çæäŸè ã¯æºåãã§ããŠããŸãããã¹ã¿ãããåŸ æ©ããŠããŸããã蚺å¯å®€ãçšæãããŠããŸãããããããæ£è ã¯æ¥ãŸããã§ããã
幎éã³ã¹ããèšç®ãããšããã®æ°åã¯äžå¿«ãªã»ã©å€§ãããªããŸããé±100ä»¶ã®äºçŽããã蚺çæã§ç¡æãã£ã³ã»ã«çã12%ã®å Žåã幎é624åã®æ£è 蚪åã倱ããŸãã1åã®èšªåãããå¹³å150ãã«ã®åçãšãããšã幎é93,600ãã«ã®åçæå€±ã«ãªããŸããæ¯å¹Žã§ãã
ããããæ¬åœã®ã³ã¹ãã¯çŽæ¥çãªåçæå€±ãè¶ ããŠããŸããç¡æãã£ã³ã»ã«ã¯ã¯ãŒã¯ãããŒãæ··ä¹±ãããã¹ã¿ãããèç«ãããå®éã«äºçŽãåžæããæ£è ã®ã¢ã¯ã»ã¹åé¡ãçã¿åºããããæ·±ãæ£è ãšã³ã²ãŒãžã¡ã³ãåé¡ã®å åãšãªããŸãã
è¯ããã¥ãŒã¹ã¯äœã§ãããããç¡æãã£ã³ã»ã«çã¯å€§å¹ ã«æ¹åå¯èœã§ããäœç³»çãªåæžæŠç¥ã宿œãã蚺çæã¯ã6ã12ã¶æä»¥å ã«ç¡æãã£ã³ã»ã«ãåæžãããããšãäžè¬çã§ãããã®æ¹åã¯çŽæ¥å©çã«åæ ãããŸãã
ç¡æãã£ã³ã»ã«ãã¿ãŒã³ã®çè§£ïŒé ããã³ã¹ã
åé¡ã解決ããåã«ããã®åœ¢ãçè§£ããå¿ èŠããããŸãããã¹ãŠã®ç¡æãã£ã³ã»ã«ãåãã§ã¯ãããŸããã
ç¡æãã£ã³ã»ã«çã®èšç®
åºæ¬çãªææšããå§ããŸã:
ç¡æãã£ã³ã»ã«ç = ç¡æãã£ã³ã»ã«æ° ÷ äºçŽç·æ° à 100
ããããããã§æ¢ãŸããªãã§ãã ãããè€æ°ã®æ¬¡å ã§ç¡æãã£ã³ã»ã«çãèšç®ããŸã:
äºçŽã¿ã€ãå¥:
- æ°æ£äºçŽ
- æ¢åæ£è ã®ãã©ããŒã¢ãã
- åŠçœ®
- å¥åº·èšºæ
æ£è ã»ã°ã¡ã³ãå¥:
- ä¿éºã¿ã€ãïŒæ°éä¿éºãMedicaidãMedicareãèªå·±è² æ ïŒ
- 幎霢局
- 蚺çæããã®å°ççè·é¢
- äºçŽå±¥æŽïŒåå vs. ãªããŒãïŒ
æéãšææ¥å¥:
- åå vs. ååŸ
- ææ¥
- æãŸãã¯å£ç¯
ãããã®å èš³ã«ãããã©ãã«åªåãéäžãã¹ãããæããã«ãªããŸããæ°æ£ã®ç¡æãã£ã³ã»ã«çã20%ã§ãæ¢åæ£è ã8%ã®å Žåãä»å ¥ã¯æ°æ£ãšã³ã²ãŒãžã¡ã³ããåªå ãã¹ãã§ãã
æ£è ã»ã°ã¡ã³ãåæ
ç°ãªãæ£è éå£ã¯ç°ãªãç¡æãã£ã³ã»ã«ãã¿ãŒã³ãæã¡ãç°ãªãä»å ¥ã«åå¿ããŸãã
æ°éä¿éºæ£è : äžè¬çã«ç¡æãã£ã³ã»ã«çãäœãïŒ6ã10%ïŒãå©äŸ¿æ§ïŒãªã³ã©ã€ã³ã¹ã±ãžã¥ãŒãªã³ã°ãããã¹ããªãã€ã³ããŒïŒã«ããåå¿ããŸãã
Medicaidæ£è : ãã°ãã°ç¡æãã£ã³ã»ã«çãé«ãïŒ15ã25%ïŒãéå£ã«ã¯äº€éææ®µãè²å ãä»äºã®ã¹ã±ãžã¥ãŒã«ãå«ãŸããŸããå人çãªã¢ãŠããªãŒããšéå£åæžã«åå¿ããŸããCMSã®Medicaidã¬ã€ãã³ã¹ã¯æ£è ãšã³ã²ãŒãžã¡ã³ãæŠç¥ã«é¢ãããªãœãŒã¹ãæäŸããŠããŸãã
Medicareæ£è : äžçšåºŠã®ç¡æãã£ã³ã»ã«çïŒ8ã15%ïŒãããã¹ããããé»è©±ã奜ã¿ãŸããäº€éææ®µãå¥åº·äžã®è€éãªèª²é¡ãããå ŽåããããŸãã
èªå·±è² æ æ£è : ã³ã¹ãæžå¿µã«å¿ããŠå€åããçãéæãªäŸ¡æ Œèšå®ãšæè»ãªæ¯æããªãã·ã§ã³ãç¡æãã£ã³ã»ã«ãåæžããŸãã
ãããã®ãã¿ãŒã³ãçè§£ããããšã§ãäžéšã«ã¯æ©èœãããä»ã«ã¯æ©èœããªãç»äžçãªè§£æ±ºçãé²ããŸãã
äºçŽã¿ã€ããã¿ãŒã³
æ°æ£äºçŽã¯ãããã€ãã®çç±ã§æãé«ãç¡æãã£ã³ã»ã«çãæã¡ãŸã:
- 蚺çæãšã®é¢ä¿ã確ç«ãããŠããªã
- ã¹ã±ãžã¥ãŒãªã³ã°ããäºçŽãŸã§ã®åŸ æ©æéãé·ã
- æ¥æ§çç¶ã§äºçŽãããäºçŽæ¥ãŸã§ã«è§£æ±ºããããšãå€ã
- 蚺çæã®ããªã·ãŒãšæåŸ ã«ç²ŸéããŠããªã
åŠçœ®äºçŽã¯æãäœãç¡æãã£ã³ã»ã«çãæã¡ãŸãããªããªã:
- æ£è ãç©æ¥µçã«åŠçœ®ãæãã§ãã
- ãã°ãã°åŠçœ®åã®æºåæè³ãå¿ èŠ
- äºçŽãéãæç¢ºãªçµæããã
ãã©ããŒã¢ããäºçŽã¯äžéã«äœçœ®ããŸã:
- 確ç«ãããé¢ä¿ã圹ç«ã€
- ãããæ£è ãæ°åãè¯ããªããšãå¿ èŠæ§ã®èªèãäœäžãã
åã¿ã€ãã®ç¹æ§ã«åãããä»å ¥ãèšèšããŸãã
ææ¥ãšæéã®ãã¬ã³ã
ã»ãšãã©ã®èšºçæã¯æ¬¡ã®ãããªãã¿ãŒã³ãèŠãŸã:
æææ¥ã®æ: ç¡æãã£ã³ã»ã«çãé«ãïŒé±æ«ã«æ°ãå€ãã£ãããå¿ããããåªå é äœãäžãããããæéãããïŒ
éææ¥ã®ååŸ: ç¡æãã£ã³ã»ã«çãé«ãïŒé±æ«ã®ç²åŽãç«¶åããèŠæ±ïŒ
é±åã°ãæŒé: ç¡æãã£ã³ã»ã«çãäœãïŒãã宿çãç«¶åããèŠæ±ãå°ãªãïŒ
æ©æãŸãã¯å€æ¹: æ£è éå£ã«ãã£ãŠå€åïŒä»äºã®ã¹ã±ãžã¥ãŒã«ãè²å ã®ããŒãºã«ããïŒ
ãããã®ãã¿ãŒã³ã䜿çšããŠã¹ã±ãžã¥ãŒã«æé©åã®æ±ºå®ã«æ å ±ãæäŸããŸããç¡æãã£ã³ã»ã«ãå€ãæéã¯ããå€ãã®ãªãŒããŒãããã³ã°ãå°ãªãæéã¯å°ãªãã®ãªãŒããŒãããã³ã°ãããŸãã
ãªãã€ã³ããŒã·ã¹ãã ã®æé©å
ãªãã€ã³ããŒã¯ç¬¬äžã®é²åŸ¡ç·ã§ããããããäžé©åã«èšèšããããªãã€ã³ããŒã·ã¹ãã ã¯ãæ£è ãã³ãã¥ãã±ãŒã·ã§ã³ãç¡èŠããããã«èšç·Žããããšã§ãå®éã«ç¡æãã£ã³ã»ã«ãå¢å ãããå¯èœæ§ããããŸãã

ãã«ããã£ãã«ã¢ãããŒã
ç°ãªãæ£è ã¯ç°ãªãã³ãã¥ãã±ãŒã·ã§ã³ãã£ãã«ã奜ã¿ãŸãããªãŒããæå€§åããããã«è€æ°ã®ãã£ãã«ã䜿çšããŸã:
ããã¹ãã¡ãã»ãŒãž:
- æãé«ãéå°çïŒ3å以å ã«95%以äžïŒ
- äºçŽç¢ºèªã«æé©
- 50æ³æªæºã®æ£è ã«å¥œãŸãã
- 160æåæªæºã«ä¿ã€
- 確èªãªã³ã¯ãŸãã¯è¿ä¿¡ãªãã·ã§ã³ãå«ãã
ã¡ãŒã«:
- è©³çŽ°ãªæ å ±ã«é©ããŠãã
- ãã©ãŒã ãæç€ºãæºåèŠä»¶ãå«ããããšãã§ãã
- SMSãããäœãéå°çïŒ20ã30%ïŒ
- 以åã«ã¡ãŒã«ã§é¢ãã£ãããšã®ããæ¢åæ£è ã«é©ããŠãã
é»è©±:
- æãããŒãœãã«ã§èª¬åŸåããã
- åŽåéçŽç
- ãªã¹ã¯ã®é«ãäºçŽïŒé«é¡ãªåŠçœ®ãé«äŸ¡å€æ£è ïŒã«æé©
- 65æ³ä»¥äžã®æ£è ã«å¥œãŸãã
Patient Portaléç¥:
- Patient Portalå°å ¥æŠç¥ãéããŠPortalãç©æ¥µçã«äœ¿çšããé¢äžããæ£è ã«æ©èœãã
- è©³çŽ°ãªæç€ºã«é©ããŠãã
- EHRã¯ãŒã¯ãããŒãšçµ±åã§ãã
- ä»ã®ãã£ãã«ããããªãŒããäœã
èªåé³å£°:
- çé»è©±ãšããã¹ãã®äžé
- çé»è©±ãããå®äŸ¡
- ããã¹ãããã詳现ãå«ããããšãã§ãã
- äžéšã®æ£è ã¯ç ©ããããšæãã
ãã¹ããã©ã¯ãã£ã¹: è€æ°ã®ãã£ãã«ãéããŸãã48æéåã«ããã¹ããªãã€ã³ããŒã24æéåã«ã¡ãŒã«ãªãã€ã³ããŒããªã¹ã¯ã®é«ãäºçŽã«ã¯é»è©±ã
ã¿ã€ãã³ã°æé©å
ãã€ãªãã€ã³ããããã¯ãã©ã®ããã«ãªãã€ã³ãããããšåããããéèŠã§ãã
ååãªãã€ã³ããŒ: 7ã10æ¥å
- å¿ èŠã«å¿ããŠã¹ã±ãžã¥ãŒã«ã調æŽããæéãæ£è ã«äžãã
- ããŸãã«ãæ©ããããšãŸãå¿ãã
- äºçŽæºåèŠä»¶ãå«ãã
ãã©ããŒã¢ãããªãã€ã³ããŒ: 48æéå
- äºçŽã«å¯Ÿããæ³šæã®ããŒã¯æé
- ãã£ã³ã»ã«ã®å Žåã蚺çæãããã¯ãã£ã«ããæéãèš±ã
- ã·ãŒã±ã³ã¹ã§æãéèŠãªãªãã€ã³ããŒ
æçµãªãã€ã³ããŒ: 24æéå
- 確èªã®æåŸã®ãã£ã³ã¹
- äžéšã®èšºçæã¯ååŸã®äºçŽã®ããã«æã«ããªãã€ã³ããŒãéã
ç°ãªãã¿ã€ãã³ã°ã·ãŒã±ã³ã¹ããã¹ãããç¡æãã£ã³ã»ã«ãžã®åœ±é¿ã枬å®ããŸããããªãã®æ£è éå£ã¯ã48æéã®ã¿ã®ãªãã€ã³ããŒããã72æéãš24æéã®ãªãã€ã³ããŒã«ããããåå¿ãããããããŸããã
ã¡ãã»ãŒãžå 容
äžè¬çãªãªãã€ã³ããŒïŒãææ¥ååŸ2æã«äºçŽããããŸããïŒã¯ã次ã®ãããªã¡ãã»ãŒãžãšæ¯èŒããŠããã©ãŒãã³ã¹ãäœäžããŸã:
ããŒãœãã©ã€ãº: ãããã«ã¡ã¯ãSarahãããJohnsonå çã¯ææ¥ååŸ2æã«ãäŒãã§ããã®ã楜ãã¿ã«ããŠããŸããã
説æè²¬ä»»ãäœã: ãããªãã®äºçŽã¯ããªãå°çšã«äºçŽãããŠããŸããæ¥ãããªãå Žåã¯ãä»ã®æ£è ã«ããªãã®æéãæäŸã§ãããããé»è©±ãã ãããã
確èªãç°¡åã«ãã: ã確èªããã«ã¯YESãšè¿ä¿¡ãåã¹ã±ãžã¥ãŒã«ããã«ã¯é»è©±ããŠãã ããããã£ã³ã»ã«ããå¿ èŠãããå Žåã¯CANCELãšè¿ä¿¡ããŠãã ãããã
䟡å€ãªãã€ã³ããŒãå«ãã: ãããªãã®å¹Žæ¬¡æ€èšºã«ã¯éèŠãªã¹ã¯ãªãŒãã³ã°ãå«ãŸããŠããŸããæ€æ»çµæãã¬ãã¥ãŒããæºåãã§ããŠããŸããã
ç°ãªãã¡ãã»ãŒãžããªãšãŒã·ã§ã³ãA/Bãã¹ãããŸããå°ããªèšèã®å€æŽãåºåžçã«æå³ã®ããéããããããå¯èœæ§ããããŸãã
確èªãªã¯ãšã¹ã
確èªãèŠæ±ããããšã§ã³ãããã¡ã³ããå¢å ããŸã:
ããã·ã確èª: ã確èªããã«ã¯YESãšè¿ä¿¡ã
- æ£è ã«ãšã£ãŠç°¡å
- 確èªãã人ãšããŠããªãäººã®æç¢ºãªããŒã¿
- æªç¢ºèªè ãžã®ç©æ¥µçãªã¢ãŠããªãŒããå¯èœã«ãã
ã¢ã¯ãã£ã確èª: ãäºçŽã確èªããã«ã¯ãããã¯ãªãã¯ã
- ãããã«æ©æŠããã
- ãã匷ãã³ãããã¡ã³ãã¡ã«ããºã
- è¿œå æ å ±ïŒä¿éºã®å€æŽãæ°ããçç¶ãªã©ïŒã®åéãå¯èœã«ãã
確èªããŠããªãæ£è ã«ãã©ããŒã¢ããããŸããç°¡åãªé»è©±ïŒããªãã€ã³ããŒãéããŸãããè¿ä¿¡ããããŸããããŸã æ¥ãäºå®ã§ãã?ãïŒã¯å€ãã®ç¡æãã£ã³ã»ã«ãé²ãããšãã§ããŸãã
ç¡æãã£ã³ã»ã«ãåæžããã¹ã±ãžã¥ãŒãªã³ã°ææ³
äºçŽãã©ã®ããã«ã¹ã±ãžã¥ãŒã«ãããã¯ãæ£è ãå®éã«æ¥ããã©ããã«å€§ãã圱é¿ããŸãã

äºåäºçŽå¶é
ã¹ã±ãžã¥ãŒãªã³ã°ãšäºçŽã®éã®ã®ã£ãããé·ãã»ã©ãç¡æãã£ã³ã»ã«çãé«ããªããŸãã
æå€§äºåäºçŽå¶éãèšå®ããŸã:
æšæºãã©ããŒã¢ãã: 4ã6é±é 宿å¥åº·èšºæ: 8ã12é±é æ°æ£äºçŽ: 2ã4é±é
ããã«å ã®äºçŽãå¿ èŠãªå Žåãé ãå°æ¥ã«äºçŽããã®ã§ã¯ãªããåžæããäºçŽæ¥ã«è¿ãææã«æ£è ã«é£çµ¡ãããªã³ãŒã«ã»å掻æ§åããã°ã©ã ã䜿çšããŸãã
äŸå€: 匷ãã¹ã±ãžã¥ãŒãªã³ã°å¶çŽïŒç¹å®ã®æ¥/æéèŠä»¶ïŒãæã€æ£è ã¯ãäºçŽãç¹å®ã®ããŒãºãæºãããããé·ãäºçŽãªãŒãã¿ã€ã ã«ããããããçŸããå¯èœæ§ãé«ããªããŸãã
ãŠã§ã€ããªã¹ãã®æŽ»çš
ã¢ã¯ãã£ããªãŠã§ã€ããªã¹ãã¯è€æ°ã®ç®çãæãããŸã:
ãã£ã³ã»ã«ãè¿ éã«ããã¯ãã£ã«: æ£è ããã£ã³ã»ã«ãããšããããã«ãŠã§ã€ããªã¹ãã®æ£è ã«æ ãæäŸããŸãã
äºåäºçŽãã¬ãã·ã£ãŒã軜æž: ã3é±éå ãŸã§äºçŽãåãŸã£ãŠããŸããããŠã§ã€ããªã¹ãã«è¿œå ããŸããããæ©ã空ããåºãããšããããããŸããã
æ£è æºè¶³åºŠãåäž: ãææ¥ç©ºãããããŸãããšããé»è©±ãåããããšã¯ç¹å¥ãªãµãŒãã¹ã®ããã«æããããŸãã
æ£è ã³ãã¥ãã±ãŒã·ã§ã³ãã©ãããã©ãŒã ãéããèªåãŠã§ã€ããªã¹ã管çã«ããããããã¹ã±ãŒã©ãã«ã«ãªããŸãããã£ã³ã»ã«ãçºçãããšãã·ã¹ãã ã¯èªåçã«é©æ ŒãªãŠã§ã€ããªã¹ãã®æ£è ã«ããã¹ããéããŸãã
ãªãŒããŒãããã³ã°æŠç¥
æŠç¥çãªãªãŒããŒãããã³ã°ã¯ãæ··ä¹±ãçã¿åºãããšãªãäºæž¬å¯èœãªç¡æãã£ã³ã»ã«ãè£ããŸãã
èšç®: ç¡æãã£ã³ã»ã«çã12%ã§ãå®éã®æ£è 蚪åã20ååžæããå Žåã23ä»¶ã®äºçŽãã¹ã±ãžã¥ãŒã«ããŸãïŒ20 ÷ 0.88 = 22.7ïŒã
ããããæŠç¥çãªãŒããŒãããã³ã°ãšã¯:
ç¡æãã£ã³ã»ã«çãé«ãäºçŽã¿ã€ãããªãŒããŒããã¯:
- ç¡æãã£ã³ã»ã«ç20%ã®æ°æ£: 25%ãªãŒããŒããã¯
- ç¡æãã£ã³ã»ã«ç8%ã®ãã©ããŒã¢ãã: 10%ãªãŒããŒããã¯
ç¡æãã£ã³ã»ã«çãé«ãæéãšææ¥ããªãŒããŒããã¯:
- æææ¥ã®æ: ããéããªãŒããŒãããã³ã°
- æ°Žææ¥ã®ååŸ: ãã軜ããªãŒããŒãããã³ã°
äžåŸã«ãªãŒããŒããã¯ããªã:
- åŠçœ®äºçŽ: ãŸãã«ãªãŒããŒããã¯
- è€éãªçžè«: æå°éã®ãªãŒããŒãããã³ã°
- ç°¡åãªãã©ããŒã¢ãã: ããç©æ¥µçãªãªãŒããŒãããã³ã°
å®éã®åºåžãé±åäœã§ç£èŠããçµæã«åºã¥ããŠãªãŒããŒãããã³ã°ããŒã»ã³ããŒãžã調æŽããŸãã
ã¯ã€ãã¯ãã£ã«ãããã³ã«
ãã£ã³ã»ã«ãçºçãããšããã¹ããŒããéèŠã§ããæ ã空ãããŸãŸã«ãªãæéã¯ããããåããæ©äŒã倱ãæéã§ãã
峿éç¥: ããã³ããã¹ã¯ã¯ãã£ã³ã»ã«ãã¹ã±ãžã¥ãŒãªã³ã°ããŒã ã«ããã«éç¥ããŸãã
ããã¯ãã£ã«ã®åªå é äœ:
- ãŠã§ã€ããªã¹ãæ£è ïŒèªåéç¥ïŒ
- åœæ¥ãªã¯ãšã¹ããªã¹ã
- ããæ©ãäºçŽãèŠæ±ããæ£è
- äžè¬æ£è éå£
æææ±ºå®æš©é: ã¹ã±ãžã¥ãŒã©ãŒã«ãäžåžã®æ¿èªãªãã§èª°ã«æ ãæäŸãããã«ã€ããŠãªã¢ã«ã¿ã€ã ã®æ±ºå®ãè¡ãæš©éãäžããŸãã
ãã¯ãããžãŒãµããŒã: é©åãªæ£è ã«ã空ãããããŸããããã¹ããèªåçã«éä¿¡ããã·ã¹ãã ã
匷åãªã¯ã€ãã¯ãã£ã«ãããã³ã«ãæã€èšºçæã¯ããã£ã³ã»ã«ã®40ã60%ãããã¯ãã£ã«ããŸããããããæããªã蚺çæã¯éåžž20%æªæºãããã¯ãã£ã«ããŸãã
æ£è ãšã³ã²ãŒãžã¡ã³ãæŠç¥
ç¡æãã£ã³ã»ã«ã«å¯ŸããæåŒ·ã®é²åŸ¡ã¯æ£è ãšã³ã²ãŒãžã¡ã³ãã§ããæ£è ã蚺çæãšã®ã€ãªãããæããé¢ä¿ã倧åã«ãããšãã圌ãã¯çŸããŸãã

é¢ä¿æ§ç¯
æ£è ã¯æ¬¡ã®å Žåã«çŸããå¯èœæ§ãé«ããªããŸã:
æäŸè ãç¥ã£ãŠãã: åãæäŸè ãšã®ç¶ç¶æ§ãç¡æãã£ã³ã»ã«ãåæžããŸãã
䟡å€ãæãã: æ£è ã®è©³çްã奜ã¿ãæžå¿µãèŠããŠãã蚺çæã¯ãã€ã€ã«ãã£ãæ§ç¯ããŸãã
質ã®é«ãã±ã¢ãçµéšãã: è¯å®çãªçµæãçµéšããæ£è ã¯ãã©ããŒã¢ããã±ã¢ã®ããã«æ»ã£ãŠããŸãã
ã¹ã¿ãããšã€ãªãã: ãã¬ã³ããªãŒã§åœ¹ç«ã€ã€ã³ã¿ã©ã¯ã·ã§ã³ãè¯å®çãªé¢é£ãäœããŸãã
ããã¯åãªãæž©ããææ§ãªãã®ã§ã¯ãããŸãããçµæžåŠã§ããæ°æ£ãç²åŸããã³ã¹ãã¯æ¢åæ£è ãç¶æããããã5ã7åé«ããªããŸããæ¢åæ£è ããã®ãã¹ãŠã®ç¡æãã£ã³ã»ã«ã¯ããªã¹ã¯ã®ããé¢ä¿æè³ã衚ããŸãã
äºçŽäŸ¡å€ã®ã³ãã¥ãã±ãŒã·ã§ã³
æ£è ã¯æã äºçŽããªãéèŠãªã®ããçè§£ããŠããŸããã䟡å€ãæç€ºçã«ããŸã:
äºé²èšªåã®å Žå: ã幎次æ€èšºã«ã¯éèŠãªããã¹ã¯ãªãŒãã³ã°ãšå¿è¡ç®¡è©äŸ¡ãå«ãŸããŠããŸããæ©æçºèŠã¯æåéãããªãã®åœãæãããšãã§ããŸããã
æ ¢æ§çŸæ£ç®¡çã®å Žå: ãç³å°¿ç ãã§ãã¯ã¢ããã¯ãè èç ãèŠååªå€±ãå¿è¡ç®¡åé¡ãªã©ã®æ·±å»ãªå䜵çãé²ãããã«è¬ã調æŽããã®ã«åœ¹ç«ã¡ãŸããã
ãã©ããŒã¢ããäºçŽã®å Žå: ããã®ãã©ããŒã¢ããã«ãããæ²»çãæ©èœããŠããããšã確èªããæ·±å»ã«ãªãåã«åé¡ãæ©æã«çºèŠã§ããŸããã
äºçŽç¢ºèªãšãªãã€ã³ããŒã«äŸ¡å€å£°æãå«ããŸãã
ã¢ã¯ã»ã¹æ¹å
æã ãæ£è ã¯äºçŽãå®ãããšãæ¬åœã«é£ããããã«ç¡æãã£ã³ã»ã«ããŸããéå£ãåæžããŸã:
䟿å©ãªã¹ã±ãžã¥ãŒãªã³ã°:
- 24æé365æ¥å©çšå¯èœãªãªã³ã©ã€ã³ã¹ã±ãžã¥ãŒãªã³ã°ã·ã¹ãã
- å»¶é·æéïŒæ©æã倿¹ã鱿«ïŒ
- ç·æ¥ã®ããŒãºã®ããã®åœæ¥äºçŽ
åŸ ã¡æéã®ççž®:
- ã¹ã±ãžã¥ãŒãªã³ã°ããäºçŽãŸã§ã§æž¬å®ïŒ10æ¥ä»¥å ã«3çªç®ã«æ¬¡ã«å©çšå¯èœïŒ
- å°çãã蚺å¯å®€ãŸã§ã§æž¬å®ïŒ15å以å ïŒ
ãã±ãŒã·ã§ã³ã®å©äŸ¿æ§:
- æ£è ãäœãã§ãã/åããŠããå Žæã«è¿ãè€æ°ã®ãã±ãŒã·ã§ã³
- é©åãªäºçŽã¿ã€ãã®ããã®Telehealthãªãã·ã§ã³
ããã»ã¹å¹ç:
- åçåããããã§ãã¯ã€ã³
- æå°éã®æžé¡äœæ¥
- å¹ççãªèšªåãããŒ
åé€ãããã¹ãŠã®æ©æŠãã€ã³ããåºåžãå¢å ãããŸãã
äº€éææ®µã®éå£
äº€éææ®µã¯ãç¹ã«MedicaidãšMedicareæ£è ã«ãšã£ãŠãç¡æãã£ã³ã»ã«ã®äž»èŠãªåå ã§ãã
解決ç:
Medicaidäº€éææ®µçµŠä»: æ£è ãä¿éºãéããŠéç·æ¥å»çäº€éææ®µãæé ããã®ãæ¯æŽããŸããCMSäº€éææ®µçµŠä»ã«é¢ããæ å ±ãæ£è ãã¬ã€ãã§ããŸãã
ã©ã€ãã·ã§ã¢ããŒãããŒã·ãã: äžéšã®èšºçæã¯Uber/LyftãšææºããŠè£å©éä»ãã®ã©ã€ããæäŸããŸãã
Telehealthä»£æ¿æ¡: ããªãã®TelehealthãµãŒãã¹æé·æŠç¥ãéããŠãé©åãªèšªåã¿ã€ãã®å Žåãäº€éææ®µã®å¿ èŠæ§ãå®å šã«æé€ããŸãã
äºçŽã®ã¯ã©ã¹ã¿ãªã³ã°: åãæ¥ã«è€æ°ã®äºçŽãã¹ã±ãžã¥ãŒã«ããŠäº€éææ®µã®åªåãæ£åœåããŸãã
æè»ãªã¹ã±ãžã¥ãŒãªã³ã°: å ¬å ±äº€éæ©é¢ã®ã¹ã±ãžã¥ãŒã«ãšã©ã€ãã®å©çšå¯èœæ§ã«å¯Ÿå¿ããŸãã
å°ããªãžã§ã¹ãã£ãŒã§ããïŒæ£è ãã©ã€ããæé ããã®ãæäŒããæç¢ºãªé§è»æç€ºãæäŸããïŒäº€éææ®µé¢é£ã®ç¡æãã£ã³ã»ã«ãåæžããŸãã
ããªã·ãŒãšèª¬æè²¬ä»»
é¢ä¿æ§ç¯ãšå©äŸ¿æ§ãçæ³çã§ããäžæ¹ãæã«ã¯èª¬æè²¬ä»»ãäœãããªã·ãŒãå¿ èŠã§ãã
ç¡æãã£ã³ã»ã«ããªã·ãŒ
æç¢ºã§äžè²«ããŠæœè¡ãããããªã·ãŒãæåŸ ãèšå®ããŸã:
ããªã·ãŒèŠçŽ :
- ç¡æãã£ã³ã»ã«ã®å®çŸ©ïŒ24æéåã®éç¥ãªãã«éããäºçŽïŒ
- ã³ãã¥ãã±ãŒã·ã§ã³èŠä»¶ïŒãã£ã³ã»ã«/åã¹ã±ãžã¥ãŒã«ããã«ã¯é»è©±ãŸãã¯Portalã䜿çšïŒ
- ç¡æãã£ã³ã»ã«ã®çµæïŒä»¥äžãåç §ïŒ
- è¯å¥œãªç¶æ ãç¶æããæ¹æ³
ã³ãã¥ãã±ãŒã·ã§ã³ã¿ã€ãã³ã°:
- æ£è ç»é²æ
- äºçŽç¢ºèªã¡ãã»ãŒãžå
- 蚺çæã®Webãµã€ããšPatient Portalå
- ãªãã£ã¹ã«æ²ç€º
æ£è ã¯ååšãç¥ããªãããªã·ãŒã«åŸãããšã¯ã§ããŸããã
ææ°æãšçµæ
ç¡æãã£ã³ã»ã«ææ°æ: äžéšã®èšºçæã¯éããäºçŽã«å¯ŸããŠæéãè«æ±ããŸãïŒéåžž25ã50ãã«ïŒãããã¯ããã©ã€ããªã±ã¢ãããéžæçå°éåéïŒç®èç§ãçŸå®¹åŠçœ®ïŒã§ãã广çã§ãã
æ³çèæ ®äºé :
- å·æ³ã確èªïŒäžéšã¯ç¡æãã£ã³ã»ã«ææ°æãå¶éïŒ
- ç¡æãã£ã³ã»ã«ã«ã€ããŠä¿éºã«è«æ±ããªã
- ææ°æããªã·ãŒãäºåã«æç¢ºã«äŒãã
- 城åã®èª²é¡ã«åãã
ã¹ã±ãžã¥ãŒãªã³ã°å¶é:
- 2ã3åã®ç¡æãã£ã³ã»ã«åŸ: 忥ã®ç¢ºèªé»è©±ãèŠæ±
- 3å以äžã®ç¡æãã£ã³ã»ã«åŸ: ãªã³ã©ã€ã³äºçŽãå¶éããé»è©±ã¹ã±ãžã¥ãŒãªã³ã°ãèŠæ±
- æ ¢æ§çãªç¡æãã£ã³ã»ã«: åæããŸãã¯é éãèŠæ±
åæŽ»æ§åèŠä»¶:
- è€æ°ã®äºçŽãéããåŸ: æ£è ã¯åäºçŽåã«ã³ãããã¡ã³ãã«ã€ããŠè©±ãåãããã«é»è©±ããªããã°ãªããªã
- 蚺çæãããŒãžã£ãŒãšã®é¢è«ãå¿ èŠãªå Žåããã
ã³ãã¥ãã±ãŒã·ã§ã³ãšæœè¡
ããªã·ãŒã¯äžè²«ããŠæœè¡ãããå Žåã«ã®ã¿æ©èœããŸã:
æåã®ç¡æãã£ã³ã»ã«åŸ:
- æ£è èšé²ã«ã¡ã¢
- 次ã®ã³ãã¥ãã±ãŒã·ã§ã³ã§ããªã·ãŒã®ãã¬ã³ããªãŒãªãªãã€ã³ããŒ
- ããã«ãã£ãªããåæã®ä»®å®
2åç®ã®ç¡æãã£ã³ã»ã«åŸ:
- çŽæ¥ã³ãã¥ãã±ãŒã·ã§ã³ïŒé»è©±ãŸãã¯æçŽïŒ
- ãã¿ãŒã³ãç¶ãå Žåã®çµæã®ãªãã€ã³ããŒ
- åºåžã®éå£ã«ã€ããŠè©±ãåãç³ãåº
3åç®ã®ç¡æãã£ã³ã»ã«åŸ:
- ããªã·ãŒæœè¡ã®æ£åŒãªéç¥
- ã¹ã±ãžã¥ãŒãªã³ã°å¶éã®é©çš
- ã³ãããã¡ã³ãã«ã€ããŠã®ææžåãããäŒè©±
ãã¹ãŠãææžå: æ£è èšé²ã®ã¡ã¢ãéä»ãããæçŽãææžåãããå£é ã§ã®äŒè©±ã
æ£è ç¶æãã©ã³ã¹
ç®æšã¯è¡åå€å®¹ã§ããã眰ã§ã¯ãããŸãããæ£è ã蚺çæãå»ãããšã§ã¯ãªããçŸããããšãæãã§ããŸãã
çè§£ãäŒŽãæœè¡ã®ãã©ã³ã¹ãåããŸã:
- æ£è ã®ç¶æ³ãèã
- çã®éå£ã«å¯Ÿãã解決çãæäŸãã
- äŸå€çãªç¶æ³ïŒæ·±å»ãªç æ°ãå®¶æã®ç·æ¥äºæ ïŒã«å¯Ÿããæè»æ§
- éå»ã®å€±æã§ã¯ãªããå°æ¥ã®ã³ãããã¡ã³ãã«çŠç¹ãåœãŠã
ä»ã®æ£è ã«å ¬å¹³ã§ãããªãããæ£è ãã±ã¢ã«ã¢ã¯ã»ã¹ããã®ãæäŒãããšããŠããããšãçè§£ããæ£è ã¯ãäžè¬çã«åççãªããªã·ãŒã«è¯å®çã«åå¿ããŸãã
枬å®ãšç¶ç¶çæ¹å
ç¡æãã£ã³ã»ã«ã®åæžã¯ãçµäºæ¥ã®ãããããžã§ã¯ãã§ã¯ãããŸãããç¶ç¶çãªç®¡çèŠåŸã§ãã
远跡ã·ã¹ãã
ãããã®ææšãæ¯æç£èŠããŸã:
å šäœçãªç¡æãã£ã³ã»ã«ç:
- 蚺çæå šäœ
- æäŸè å¥
- ãã±ãŒã·ã§ã³å¥ïŒãã«ããã±ãŒã·ã§ã³ã®å ŽåïŒ
ã»ã°ã¡ã³ãå¥ç¡æãã£ã³ã»ã«ç:
- äºçŽã¿ã€ã
- æ£è éå£
- ææ¥ãšæé
- ä¿éºã¿ã€ã
ãªãã€ã³ããŒã®æå¹æ§:
- ãã£ãã«å¥ç¢ºèªç
- ç¢ºèªæžã¿ vs. æªç¢ºèªã®ç¡æãã£ã³ã»ã«ç
ããªã·ãŒã®åœ±é¿:
- 0ã1ã2ã3å以äžã®äºåç¡æãã£ã³ã»ã«ãæã€æ£è ã®ç¡æãã£ã³ã»ã«ç
- ããªã·ãŒå®è£ ååŸ
財åç圱é¿:
- ç¡æãã£ã³ã»ã«ã§å€±ãããåç
- ããã¯ãã£ã«ã«ããå埩
ãã¬ã³ããç¹å®ããä»å ¥ã®åœ±é¿ã枬å®ã§ããããã«ãHealthcareå®è·µã¡ããªã¯ã¹ãäžè²«ããŠè¿œè·¡ããŸãã
ç®æšèšå®
å ·äœçã§æž¬å®å¯èœãªç®æšãèšå®ããŸã:
ããã»ã¹ç®æš:
- ãã¹ãŠã®äºçŽã§90%ã®ç¢ºèªç
- 24æé以å ã®ãã£ã³ã»ã«ã§50%ã®ããã¯ãã£ã«ç
- ç»é²æã®100%æ£è ããªã·ãŒã³ãã¥ãã±ãŒã·ã§ã³
çµæç®æš:
- 6ã¶æä»¥å ã«å šäœçãªç¡æãã£ã³ã»ã«çã12%ãã8%ã«åæž
- 3ã¶æä»¥å ã«æ°æ£ã®ç¡æãã£ã³ã»ã«ã18%ãã12%ã«åæž
- ç¡æãã£ã³ã»ã«åæžãã幎é30,000ãã«ã®åçå¢å
幎éç®æšãååæããšã®ãã€ã«ã¹ããŒã³ã«åå²ããŸããéäžã§é²æãç¥ããŸãã
ç¶ç¶çãªæ¹è¯
æ©èœãããã®ã¯ãæ£è éå£ããã¯ãããžãŒãç¶æ³ãå€åããã«ã€ããŠé²åããŸãã
ååæã¬ãã¥ãŒ:
- ã©ã®ä»å ¥ã枬å®å¯èœãªåœ±é¿ã瀺ããã?
- ã©ã®ä»å ¥ã圱é¿ã瀺ãããäžæ¢ãã¹ãã?
- ã©ã®æ°ããæŠç¥ããã¹ããã¹ãã?
幎次深æã:
- ãã¹ãŠã®ã»ã°ã¡ã³ãã«ãããå æ¬çãªããŒã¿åæ
- äºçŽã®éå£ãšå¥œã¿ã«é¢ããæ£è 調æ»
- ããã»ã¹ã«é¢ããã¹ã¿ããã®ãã£ãŒãããã¯
- åå¹Žãšæ¥çåºæºã«å¯Ÿãããã³ãããŒã¯
ç¶ç¶çãªãã¹ã:
- ãªãã€ã³ããŒã®ã¿ã€ãã³ã°ãšå 容ã®A/Bãã¹ã
- æ°ãããã¯ãããžãŒã®ãã€ãããïŒAIæèŒã®ã¢ãŠããªãŒããã¹ããŒããŠã§ã€ããªã¹ãïŒ
- ç°ãªããªãŒããŒãããã³ã°æŠç¥ã®ãã¹ã
- äºçŽã¿ã€ããšæéã®å®éš
ç¡æãã£ã³ã»ã«ã®åæžã«æåãã蚺çæã¯å ±éã®ç¹æ§ãå ±æããŠããŸã: 圌ãã¯ãããäžåºŠè§£æ±ºããŠå¿ããåé¡ã§ã¯ãªããäœç³»çãªç®¡çã®åªå äºé ãšããŠæ±ããŸãã
ç¡æãã£ã³ã»ã«ã¯é¿ããããªããã®ã§ã¯ãããŸããããããã¯ä¿¡å·ã§ãããªãã€ã³ããŒã·ã¹ãã ãæ¹åãå¿ èŠã§ããããšãäžéšã®æ£è ãã±ã¢ãžã®éå£ã«çŽé¢ããŠããããšãã¹ã±ãžã¥ãŒãªã³ã°ææ³ããªã¹ã¯ãçã¿åºããŠããããšããŸãã¯æ£è ãšã³ã²ãŒãžã¡ã³ãã匷åãå¿ èŠã§ããããšã®ä¿¡å·ã§ãã
ãããã®ä¿¡å·ãè§£èªããäœç³»çã«å¯Ÿå¿ãããšãåçæå€±ãåæžããã ãã§ãªããæ£è ã¢ã¯ã»ã¹ãæ¹åããé¢ä¿ã匷åããäºçŽã¹ã±ãžã¥ãŒãªã³ã°æé©åã®åªåãæé©åããæ£è ãå®éã«çŸããã®ã«ååãªäŸ¡å€ã®ãã蚺çæãæ§ç¯ããŸãã
ããã¯å©çã ãã§ãªããæ£è ã®å¥åº·çµæã«ãšã£ãŠãè¯ãããšã§ããéããäºçŽã¯ãã¹ãŠãå¥åº·ç¶æ ãäºé²ãæ€åºããŸãã¯ç®¡çããæ©äŒãéãããšã§ãã
ããªãã®æ£è ã¯ããªããå¿ èŠãšããŠããŸããããªãã®ä»äºã¯ãçŸããããšãã§ããã ãç°¡åã§äŸ¡å€ã®ãããã®ã«ããããšã§ãããããæ£ããè¡ããšãç¡æãã£ã³ã»ã«åé¡ã¯ã»ãšãã©èªå·±è§£æ±ºããŸãã

Senior Operations & Growth Strategist
On this page
- 無断キャンセルパターンの理解:隠れたコスト
- 無断キャンセル率の計算
- 患者セグメント分析
- 予約タイプパターン
- 曜日と時間のトレンド
- リマインダーシステムの最適化
- マルチチャネルアプローチ
- タイミング最適化
- メッセージ内容
- 確認リクエスト
- 無断キャンセルを削減するスケジューリング手法
- 事前予約制限
- ウェイトリストの活用
- オーバーブッキング戦略
- クイックフィルプロトコル
- 患者エンゲージメント戦略
- 関係構築
- 予約価値のコミュニケーション
- アクセス改善
- 交通手段の障壁
- ポリシーと説明責任
- 無断キャンセルポリシー
- 手数料と結果
- コミュニケーションと施行
- 患者維持バランス
- 測定と継続的改善
- 追跡システム
- 目標設定
- 継続的な改良